ArticleInvestigational new drugs2017

Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery.

Juhong Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.